Atlas Trials

A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma

Clinical trial NCT03847896 · COMPLETED

Trial details

NCT number
NCT03847896
Sponsor
Bond Avillion 2 Development LP
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Asthma
Start date
2019-03-20
Primary completion
2021-07-20
Enrollment
1001

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.